Diverse compound library and high-throughput chemistry services for drug discovery
Access a curated library of 300+ synthetic compounds with proven diversity, stability, and synthetic versatility. Complementary high-throughput chemistry capabilities enable rapid production of purified compounds (10-100mg scale) across compatible scaffolds.
Overview
This offering provides access to a proprietary library of more than 300 synthetic compounds developed through prior medicinal chemistry efforts. The collection is designed to deliver broad chemical diversity, demonstrated stability, and synthetic versatility, making it a valuable starting point for drug discovery programs, lead optimization campaigns, and scaffold exploration. Beyond the existing library, high-throughput chemistry capabilities are available to produce several hundred additional purified compounds at the 10-100 mg scale, supporting hit-to-lead expansion and focused library generation.
Technical specifications
Key features:
- A curated set of 300+ compounds representing diverse chemical scaffolds
- Compounds selected for usefulness in medicinal chemistry and drug discovery workflows
- Validated stability profiles suitable for screening and storage
- Synthetic routes designed as hubs enabling access to multiple follow-up compound classes
- High-throughput chemistry platform capable of producing 10-100 mg quantities per compound
- Scalable production of several hundred purified compounds on demand
- HT chemistry applicable to compatible scaffold families
Technology readiness level
The compound library reflects accumulated synthetic efforts with established characterization and demonstrated synthetic accessibility. High-throughput chemistry capabilities are operational and ready to support custom compound production requests. The offering is well-suited for collaborative evaluation, pilot screening, and integration into ongoing discovery programs.
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a major academic medical center integrating patient care, education, and research for the University of Groningen. Co-location of the tertiary hospital with research facilities enables rapid clinical translation, access to diverse patient populations, and coordinated clinical trials support. An adjacent innovation campus and incubators, plus a dedicated technology transfer office, facilitate sponsored research, licensing, and startup formation with corporate partners. Research is backed by competitive funding from national agencies and the European Union, including programs of the Dutch Research Council and health research funders. Robust quality systems, compliance, and data governance enable industry-grade collaborations at scale.
delivered to your inbox.